×
Internet Explorer

Ваш браузер устарел

Пожалуйста, обновите браузер — из-за старой версии браузера сайт может работать неправильно и представлять угрозу вашей безопасности.

scroll up scroll down

The production of 20 vital medicines will be opened in the Technopolis Moscow

Share this
Print
Copy link

The SEZ resident received a license for the production of medicines and the EAEU GMP certificate confirming compliance with high production quality standards. By the end of 2022, the company plans to start manufacturing 20 drugs for the treatment of HIV infection, cancer, kidney failure, anticoagulants, chelators and insulins. The first batches of drugs will amount to more than 10,000 packages. After production reaches full capacity by 2024, the company will be ready to produce up to 2 m packages per year.

In total, the resident has already developed more than 60 drugs belonging to various pharmacological groups.

More on the topic